Analyzing Healthcare

In this conversation, Dr. Robert Fields, an expert in population health, shares his journey from being a family doctor to a leader in healthcare. He discusses the complexities of population health, the differences between ACOs and traditional healthcare systems, and the challenges faced by Medicare Advantage. The conversation delves into the role of consumerism in healthcare and the future of value-based care, highlighting the need for a shift in how healthcare is delivered and financed. In this conversation, the speakers delve into the complexities of Accountable Care Organizations (ACOs) and their value in the healthcare system. They discuss the evolution of care coordination, the challenges faced in population health management, and the importance of addressing social determinants of health. The conversation highlights innovative approaches to social care and the need for a more integrated healthcare system that prioritizes patient outcomes and community well-being.

Title: Understanding Population Health: Challenges and Opportunities with Dr. Robert Fields.

Key Timestamps:

• (00:00) Introduction to Population Health and Dr. Robert Fields
• (04:51) Dr. Fields' Journey in Healthcare Leadership
• (09:58) Understanding Population Health: Definitions and Perspectives
• (15:04) The Role of ACOs in Population Health
• (20:08) Challenges in Medicare Advantage vs. Traditional Medicare
• (25:12) Consumerism and the Healthcare System
• (29:58) The Future of Value-Based Care and ACOs
• (34:19) Evaluating the Value of ACOs
• (39:22) The Evolution of Care Coordination
• (45:00) Challenges in Population Health Management
• (52:25) Addressing Social Determinants of Health
• (01:00:01) Innovative Approaches to Social Care

Key Takeaways:

• Dr. Fields stresses the importance of viewing population health beyond individual care.
• His journey highlights the challenge of aligning healthcare economics with patient care.
• ACOs are essential for managing population health effectively.
• Medicare Advantage presents unique challenges compared to traditional Medicare.
• Consumerism influences healthcare decisions, but the system often misaligns with patient needs.
• Value-based care is still evolving, and its success depends on system adaptation.
• Transparency in healthcare costs and outcomes is crucial.
• The effectiveness of ACOs varies, with Medicare Shared Savings ACOs being more trusted.
• Care coordination is critical but remains a complex, evolving aspect of healthcare.
• Social determinants significantly impact patient outcomes.
• Innovative approaches and nonprofit collaboration can enhance community health.
• The healthcare industry must address its moral responsibilities to patients.
• Economic incentives can drive improvements in social care.

linkedin.com/in/robfieldsmd

linkedin.com/in/roy-bejarano-a5669ba8

www.scale-community.com

About the Guest:

Dr. Robert Fields is a leader in healthcare quality, population health, and value-based care. As EVP and Chief Clinical Officer at Beth Israel Lahey Health, he oversees key clinical services. Previously, at Mount Sinai, he advanced care delivery and health equity. Co-founder of Vista Family Health, he champions linking social care to healthcare for better outcomes.

Keywords:

Population Health, Healthcare Leadership, ACOs, Medicare Advantage, Value-Based Care, Healthcare Economics, Chronic Disease Management, Healthcare Policy, Consumerism in Healthcare, Healthcare System Challenges, ACOs, Healthcare, Value-Based Care, Care Coordination, Population Health, Social Determinants of Health, Medicare, Medicaid, Healthcare Innovation, Health Systems, Analyzing Healthcare, Roy Bejarano, Jason Schifman, Healthcare, Healthcare Leadership, Healthcare Trends

In this conversation, Dr. Robert Fields, an expert in population health, shares his journey from being a family doctor to a leader in healthcare. He discusses the complexities of population health, the differences between ACOs and traditional healthcare systems, and the challenges faced by Medicare Advantage. The conversation delves into the role of consumerism in healthcare and the future of value-based care, highlighting the need for a shift in how healthcare is delivered and financed. In this conversation, the speakers delve into the complexities of Accountable Care Organizations (ACOs) and their value in the healthcare system. They discuss the evolution of care coordination, the challenges faced in population health management, and the importance of addressing social determinants of health. The conversation highlights innovative approaches to social care and the need for a more integrated healthcare system that prioritizes patient outcomes and community well-being.

Title: Understanding Population Health: Challenges and Opportunities with Dr. Robert Fields

Key Timestamps:

• (00:00) Introduction to Population Health and Dr. Robert Fields
• (04:51) Dr. Fields' Journey in Healthcare Leadership
• (09:58) Understanding Population Health: Definitions and Perspectives
• (15:04) The Role of ACOs in Population Health
• (20:08) Challenges in Medicare Advantage vs. Traditional Medicare
• (25:12) Consumerism and the Healthcare System
• (29:58) The Future of Value-Based Care and ACOs
• (34:19) Evaluating the Value of ACOs
• (39:22) The Evolution of Care Coordination
• (45:00) Challenges in Population Health Management
• (52:25) Addressing Social Determinants of Health
• (01:00:01) Innovative Approaches to Social Care

Key Takeaways:

• Dr. Fields stresses the importance of viewing population health beyond individual care.
• His journey highlights the challenge of aligning healthcare economics with patient care.
• ACOs are essential for managing population health effectively.
• Medicare Advantage presents unique challenges compared to traditional Medicare.
• Consumerism influences healthcare decisions, but the system often misaligns with patient needs.
• Value-based care is still evolving, and its success depends on system adaptation.
• Transparency in healthcare costs and outcomes is crucial.
• The effectiveness of ACOs varies, with Medicare Shared Savings ACOs being more trusted.
• Care coordination is critical but remains a complex, evolving aspect of healthcare.
• Social determinants significantly impact patient outcomes.
• Innovative approaches and nonprofit collaboration can enhance community health.
• The healthcare industry must address its moral responsibilities to patients.
• Economic incentives can drive improvements in social care.

⁠linkedin.com/in/robfieldsmd⁠

⁠linkedin.com/in/roy-bejarano-a5669ba8⁠

⁠www.scale-community.com ⁠

About the Guest:

Dr. Robert Fields is a leader in healthcare quality, population health, and value-based care. As EVP and Chief Clinical Officer at Beth Israel Lahey Health, he oversees key clinical services. Previously, at Mount Sinai, he advanced care delivery and health equity. Co-founder of Vista Family Health, he champions linking social care to healthcare for better outcomes.

Keywords:

Population Health, Healthcare Leadership, ACOs, Medicare Advantage, Value-Based Care, Healthcare Economics, Chronic Disease Management, Healthcare Policy, Consumerism in Healthcare, Healthcare System Challenges, ACOs, Healthcare, Value-Based Care, Care Coordination, Population Health, Social Determinants of Health, Medicare, Medicaid, Healthcare Innovation, Health Systems, Analyzing Healthcare, Roy Bejarano, Jason Schifman, Healthcare, Healthcare Leadership, Healthcare Trends

In this podcast episode, Jason Schifman interviews Suzanne Steinbaum, founder and CEO of Adesso, a company dedicated to improving cardiovascular care for women. They discuss the alarming statistics surrounding women's heart health, the unique challenges faced by female patients, and how Adesso's tailored care management platform aims to address these issues. The conversation covers the importance of prevention, the differences in treatment between men and women, and the innovative approach Adesso takes to engage patients and improve outcomes. Suzanne shares insights on the company's growth strategy, partnerships, and future developments in their platform.

Title: The Future of Cardiovascular Care Tech Tailored for Women with Dr. Suzanne Steinbaum

Key Timestamps: 

• (00:00) Introduction to Cardiovascular Care for Women
• (02:53) Understanding the Statistics: Women's Heart Health
• (05:57) The Unique Challenges of Women's Cardiovascular Disease
• (09:07) Introducing Adesso: A Tailored Care Management Platform
• (11:47) Patient Experience: Standard Care vs. Adesso's Approach
• (15:09) Ongoing Care and Patient Engagement with Adesso
• (17:54) Adesso's Market Footprint and Growth Strategy
• (21:07) Partnerships and Coordination in Cardiovascular Care
• (23:52) Data-Driven Care: Algorithms and Outcomes
• (27:00) Future Directions and Product Development for Adesso
• (30:10) Challenges in Scaling and Replicating Success

Key Takeaways: 

• One in three women die of heart disease, more than all cancers combined.
• 80% of heart disease is preventable, highlighting the need for prevention strategies.
• Women experience heart disease differently than men, often with worse outcomes.
• Adesso focuses on a tailored approach to cardiovascular care for women.
• The platform integrates with primary care to manage heart health proactively.
• Patient engagement is crucial; Adesso uses an app for ongoing communication.
• The company has seen a significant re-engagement of patients through its platform.
• Adesso is expanding its reach through partnerships with ACOs and other healthcare providers.
• Data-driven algorithms are used to assess patient risk and guide treatment.
• Future developments include a men's version of the platform and integration of various health management solutions.

About the Guest:

Dr. Suzanne Steinbaum, a leading cardiologist, entrepreneur, and advocate for women's heart health. With decades of experience at top hospitals, she pioneers technology-driven solutions to prevent heart disease. Through Adesso she is reshaping cardiac care and empowering women to take control of their heart health.

Keywords:

Cardiovascular Care, Women's Health, Heart Disease Prevention, Adesso, Healthcare Technology, Patient Engagement, Care Management, Health Statistics, Women's Heart Health, Preventive Care, Analyzing Healthcare, Roy Bejarano, Jason Schifman, Healthcare, Healthcare Leadership, Healthcare Trends

In this podcast episode, Jason Schifman interviews Suzanne Steinbaum, founder and CEO of Adesso, a company dedicated to improving cardiovascular care for women. They discuss the alarming statistics surrounding women's heart health, the unique challenges faced by female patients, and how Adesso's tailored care management platform aims to address these issues. The conversation covers the importance of prevention, the differences in treatment between men and women, and the innovative approach Adesso takes to engage patients and improve outcomes. Suzanne shares insights on the company's growth strategy, partnerships, and future developments in their platform.

Title: The Future of Cardiovascular Care Tech Tailored for Women with Dr. Suzanne Steinbaum

Key Timestamps: 

• (00:00) Introduction to Cardiovascular Care for Women
• (02:53) Understanding the Statistics: Women's Heart Health
• (05:57) The Unique Challenges of Women's Cardiovascular Disease
• (09:07) Introducing Adesso: A Tailored Care Management Platform
• (11:47) Patient Experience: Standard Care vs. Adesso's Approach
• (15:09) Ongoing Care and Patient Engagement with Adesso
• (17:54) Adesso's Market Footprint and Growth Strategy
• (21:07) Partnerships and Coordination in Cardiovascular Care
• (23:52) Data-Driven Care: Algorithms and Outcomes
• (27:00) Future Directions and Product Development for Adesso
• (30:10) Challenges in Scaling and Replicating Success

Key Takeaways: 

• One in three women die of heart disease, more than all cancers combined.
• 80% of heart disease is preventable, highlighting the need for prevention strategies.
• Women experience heart disease differently than men, often with worse outcomes.
• Adesso focuses on a tailored approach to cardiovascular care for women.
• The platform integrates with primary care to manage heart health proactively.
• Patient engagement is crucial; Adesso uses an app for ongoing communication.
• The company has seen a significant re-engagement of patients through its platform.
• Adesso is expanding its reach through partnerships with ACOs and other healthcare providers.
• Data-driven algorithms are used to assess patient risk and guide treatment.
• Future developments include a men's version of the platform and integration of various health management solutions.

About the Guest:

Dr. Suzanne Steinbaum, a leading cardiologist, entrepreneur, and advocate for women's heart health. With decades of experience at top hospitals, she pioneers technology-driven solutions to prevent heart disease. Through Adesso she is reshaping cardiac care and empowering women to take control of their heart health.

Keywords:

Cardiovascular Care, Women's Health, Heart Disease Prevention, Adesso, Healthcare Technology, Patient Engagement, Care Management, Health Statistics, Women's Heart Health, Preventive Care, Analyzing Healthcare, Roy Bejarano, Jason Schifman, Healthcare, Healthcare Leadership, Healthcare Trends

Roy Bejarano hosts Brendan Ballou on Analyzing Healthcare to discuss his book Plunder and private equity’s impact on the U.S. economy. Ballou explores its dual nature—value creation vs. short-term risks—along with legal and regulatory challenges. The conversation covers ownership dynamics, risk management, and transaction implications. It highlights private equity’s conservative approach, healthcare investments, and the need for greater transparency and accountability.

Title: Private Equity Under the Microscope: Incentives, Liability, and the Transactional Truth with Brendan Ballou

Key Timestamps:

• (00:00) Introduction to Private Equity and Brendan Ballou
• (03:05) The Research Behind 'Plunder' and Private Equity's Impact
• (06:12) The Dual Nature of Private Equity: Pillaging vs. Building
• (08:54) Regulatory Challenges and Public Perception of Private Equity
• (11:51) Incentives and Fee Structures in Private Equity
• (14:55) Long-term vs. Short-term Perspectives in Private Equity
• (18:12) The Role of Legal Incentives in Private Equity
• (21:01) Conclusion: Balancing Perspectives on Private Equity
• (27:37) Understanding Private Equity Ownership Dynamics
• (30:01) The Risk Landscape in Private Equity
• (33:57) Transaction Risks and Their Implications
• (40:18) Private Equity's Focus on Healthcare Investments
• (52:23) Regulatory Considerations and Industry Accountability

Key Takeaways:

• Plunder critiques private equity’s impact on America.
• Private equity firms often shield themselves from legal consequences.
• Fee structures incentivize short-term gains.
• Many private equity portfolios have a 90% success rate.
• Legal incentives can misalign firm interests.
• Public perception is often negative due to anecdotal cases.
• Long-term investment approaches yield better results.
• Private equity professionals are not inherently malicious.
• Regulatory challenges remain significant.
• A balanced view is needed for informed discussions.
• Ownership can be majority or minority, affecting control.
• Transaction risks outweigh litigation risks.
• Ownership changes introduce governance challenges.
• Private equity firms tend to be conservative and risk-averse.
• Investment bankers shape transaction risk landscapes.
• Healthcare investments are often misrepresented.
• Regulatory frameworks need updates for accountability.
• Transparency is key to building public trust.
• Inflated valuations pose systemic risks.
• Risk management is often reactive, not proactive.

⁠⁠linkedin.com/in/brendan-ballou-2546801b7⁠⁠

⁠⁠www.scale-community.com ⁠⁠

About the Guest:

Brendan Ballou, author of "Plunder," critically examines private equity's influence on America. As a former federal prosecutor, including Special Counsel for Private Equity at the Justice Department, he brings unique legal insight. Ballou exposes risks like excessive debt and limited liability, driving vital discussions on industry regulation and its societal impact. His work sparks debate on accountability and economic fairness.

Keywords:

Private Equity, Brendan Ballou, Plunder, Legal Incentives, Short-term Thinking, Long-term Investment, Regulatory Challenges, Fee Structures, Public Perception, Healthcare, private equity, ownership dynamics, risk management, healthcare investments, regulatory accountability, transaction risks, investment strategies, legal insulation, corporate governance, financial incentives, Analyzing Healthcare, Roy Bejarano, Jason Schifman, Healthcare Leadership, Healthcare Trends

Roy Bejarano hosts Brendan Ballou on Analyzing Healthcare to discuss his book Plunder and private equity’s impact on the U.S. economy. Ballou explores its dual nature—value creation vs. short-term risks—along with legal and regulatory challenges. The conversation covers ownership dynamics, risk management, and transaction implications. It highlights private equity’s conservative approach, healthcare investments, and the need for greater transparency and accountability.

Title: Private Equity Under the Microscope: Incentives, Liability, and the Transactional Truth with Brendan Ballou

Key Timestamps:

• (00:00) Introduction to Private Equity and Brendan Ballou
• (03:05) The Research Behind 'Plunder' and Private Equity's Impact
• (06:12) The Dual Nature of Private Equity: Pillaging vs. Building
• (08:54) Regulatory Challenges and Public Perception of Private Equity
• (11:51) Incentives and Fee Structures in Private Equity
• (14:55) Long-term vs. Short-term Perspectives in Private Equity
• (18:12) The Role of Legal Incentives in Private Equity
• (21:01) Conclusion: Balancing Perspectives on Private Equity
• (27:37) Understanding Private Equity Ownership Dynamics
• (30:01) The Risk Landscape in Private Equity
• (33:57) Transaction Risks and Their Implications
• (40:18) Private Equity's Focus on Healthcare Investments
• (52:23) Regulatory Considerations and Industry Accountability

Key Takeaways:

• Plunder critiques private equity’s impact on America.
• Private equity firms often shield themselves from legal consequences.
• Fee structures incentivize short-term gains.
• Many private equity portfolios have a 90% success rate.
• Legal incentives can misalign firm interests.
• Public perception is often negative due to anecdotal cases.
• Long-term investment approaches yield better results.
• Private equity professionals are not inherently malicious.
• Regulatory challenges remain significant.
• A balanced view is needed for informed discussions.
• Ownership can be majority or minority, affecting control.
• Transaction risks outweigh litigation risks.
• Ownership changes introduce governance challenges.
• Private equity firms tend to be conservative and risk-averse.
• Investment bankers shape transaction risk landscapes.
• Healthcare investments are often misrepresented.
• Regulatory frameworks need updates for accountability.
• Transparency is key to building public trust.
• Inflated valuations pose systemic risks.
• Risk management is often reactive, not proactive.

⁠linkedin.com/in/brendan-ballou-2546801b7⁠

⁠www.scale-community.com ⁠

About the Guest:

Brendan Ballou, author of "Plunder," critically examines private equity's influence on America. As a former federal prosecutor, including Special Counsel for Private Equity at the Justice Department, he brings unique legal insight. Ballou exposes risks like excessive debt and limited liability, driving vital discussions on industry regulation and its societal impact. His work sparks debate on accountability and economic fairness.

Keywords:

Private Equity, Brendan Ballou, Plunder, Legal Incentives, Short-term Thinking, Long-term Investment, Regulatory Challenges, Fee Structures, Public Perception, Healthcare, private equity, ownership dynamics, risk management, healthcare investments, regulatory accountability, transaction risks, investment strategies, legal insulation, corporate governance, financial incentives, Analyzing Healthcare, Roy Bejarano, Jason Schifman, Healthcare Leadership, Healthcare Trends

In this episode, Tim Atterbury, CEO of Cardiovascular Associates of America (CVA USA), discusses the innovative approaches and structural changes being implemented in the cardiovascular care sector. He emphasizes the importance of empowering entrepreneurial cardiologists, integrating various aspects of care delivery, and navigating the complexities of risk-based reimbursement models. The conversation highlights the need for innovation, experimentation, and collaboration within the healthcare ecosystem to improve patient outcomes and reduce costs. This conversation delves into the evolving landscape of cardiology, focusing on patient management, collaborative care models, and the importance of risk-based contracting. The speakers discuss the challenges and opportunities presented by technology, strategic partnerships, and the role of private equity in shaping the future of healthcare. Emphasis is placed on the need for transparency and sustainability in operations, as well as the importance of adapting to geographic constraints and market dynamics.

Title: How CVAUSA is Transforming Cardiology with Innovation, Risk-Based Models, and Patient-Centric Solutions with Tim Attebery 

Key Timestamps: 

• (00:00) Introduction to CVA USA and Its Mission
• (02:49) The Evolution of Cardiovascular Care
• (05:46) Building a Comprehensive Care Model
• (09:09) Innovative Approaches to Patient Care
• (12:07) Risk-Based Reimbursement in Cardiology
• (15:02) Fostering Innovation and Experimentation
• (18:13) Navigating the Future of Cardiovascular Care
• (28:41) Understanding Patient Management in Cardiology
• (30:01) Collaborative Care Models with Primary Care
• (32:45) Risk-Based Contracting in Cardiology
• (34:40) Geographic Constraints in Risk Models
• (35:42) Exploring Strategic Partnerships
• (37:27) Impact of Technology in Cardiology
• (41:43) Building a Modern MSO
• (46:02) Future Challenges in Cardiology
• (49:19) The Role of Private Equity in Healthcare

Key Takeaways: 

• CVA USA has 160+ locations and 550+ providers.
• The mission is to empower specialists to improve care.
• Clinical, operational, and financial integration is key.
• Data analytics and advanced practice providers are vital.
• Risk-based contracting helps control patient care costs.
• Home-based cardiac rehab improves accessibility.
• Innovation and transparency are encouraged.
• CVA USA manages the full spectrum of cardiovascular care.
• The goal is quality care while reducing avoidable costs.
• 10% of patients don’t respond to primary care.
• Collaborative models are crucial for complex cases.
• Geography affects risk model implementation.
• Partnerships with primary care improve patient management.
• Technology is essential in modern cardiology.
• A modern MSO must prioritize quality and compliance.
• Medicare policies shape cardiology’s future.
• Private equity drives healthcare innovation.
• Long-term success requires sustainability and execution.

linkedin.com/in/jasonschifman 

linkedin.com/in/timothy-attebery-dsc-mba-fache-b06442b6

www.scale-community.com 

About the Guest:

Dr. Tim Attebery is a leader in cardiovascular care, driving innovation and technology. As CEO of CVAUSA and former CEO of the American College of Cardiology, he has advanced physician-led healthcare, improved cardiac imaging, and optimized hospital systems. His work continues to drive innovation in cardiovascular medicine and patient care.

Keywords

CVA USA, cardiovascular care, risk-based reimbursement, healthcare innovation, patient care, MSO, healthcare technology, entrepreneurial cardiology, value-based care, healthcare ecosystem, cardiology, patient management, primary care, risk-based contracting, healthcare technology, strategic partnerships, MSO, private equity, healthcare innovation, collaborative care, Analyzing Healthcare, Roy Bejarano, Jason Schifman, Healthcare, Healthcare Leadership, Healthcare Trends

In this episode, Tim Attebery, CEO of Cardiovascular Associates of America (CVA USA), discusses the innovative approaches and structural changes being implemented in the cardiovascular care sector. He emphasizes the importance of empowering entrepreneurial cardiologists, integrating various aspects of care delivery, and navigating the complexities of risk-based reimbursement models. The conversation highlights the need for innovation, experimentation, and collaboration within the healthcare ecosystem to improve patient outcomes and reduce costs. This conversation delves into the evolving landscape of cardiology, focusing on patient management, collaborative care models, and the importance of risk-based contracting. The speakers discuss the challenges and opportunities presented by technology, strategic partnerships, and the role of private equity in shaping the future of healthcare. Emphasis is placed on the need for transparency and sustainability in operations, as well as the importance of adapting to geographic constraints and market dynamics.

Title: How CVAUSA is Transforming Cardiology with Innovation, Risk-Based Models, and Patient-Centric Solutions with Tim Attebery 

Key Timestamps: 

• (00:00) Introduction to CVA USA and Its Mission
• (02:49) The Evolution of Cardiovascular Care
• (05:46) Building a Comprehensive Care Model
• (09:09) Innovative Approaches to Patient Care
• (12:07) Risk-Based Reimbursement in Cardiology
• (15:02) Fostering Innovation and Experimentation
• (18:13) Navigating the Future of Cardiovascular Care
• (28:41) Understanding Patient Management in Cardiology
• (30:01) Collaborative Care Models with Primary Care
• (32:45) Risk-Based Contracting in Cardiology
• (34:40) Geographic Constraints in Risk Models
• (35:42) Exploring Strategic Partnerships
• (37:27) Impact of Technology in Cardiology
• (41:43) Building a Modern MSO
• (46:02) Future Challenges in Cardiology
• (49:19) The Role of Private Equity in Healthcare

Key Takeaways: 

• CVA USA has 160+ locations and 550+ providers.
• The mission is to empower specialists to improve care.
• Clinical, operational, and financial integration is key.
• Data analytics and advanced practice providers are vital.
• Risk-based contracting helps control patient care costs.
• Home-based cardiac rehab improves accessibility.
• Innovation and transparency are encouraged.
• CVA USA manages the full spectrum of cardiovascular care.
• The goal is quality care while reducing avoidable costs.
• 10% of patients don’t respond to primary care.
• Collaborative models are crucial for complex cases.
• Geography affects risk model implementation.
• Partnerships with primary care improve patient management.
• Technology is essential in modern cardiology.
• A modern MSO must prioritize quality and compliance.
• Medicare policies shape cardiology’s future.
• Private equity drives healthcare innovation.
• Long-term success requires sustainability and execution.

linkedin.com/in/jasonschifman 

linkedin.com/in/timothy-attebery-dsc-mba-fache-b06442b6

www.scale-community.com 

About the Guest:

Dr. Tim Attebery is a leader in cardiovascular care, driving innovation and technology. As CEO of CVAUSA and former CEO of the American College of Cardiology, he has advanced physician-led healthcare, improved cardiac imaging, and optimized hospital systems. His work continues to drive innovation in cardiovascular medicine and patient care.

Keywords

CVA USA, cardiovascular care, risk-based reimbursement, healthcare innovation, patient care, MSO, healthcare technology, entrepreneurial cardiology, value-based care, healthcare ecosystem, cardiology, patient management, primary care, risk-based contracting, healthcare technology, strategic partnerships, MSO, private equity, healthcare innovation, collaborative care, Analyzing Healthcare, Roy Bejarano, Jason Schifman, Healthcare, Healthcare Leadership, Healthcare Trends

Roy Bejarano sits down with Dr. Robin Smith and Dr. Andrew Von Eschenbach as they delve into the evolving field of regenerative medicine, focusing on stem cell therapy and its applications. In this episode, they discuss the history, current trends, and future potential of regenerative medicine, emphasizing the importance of exosomes and the challenges faced in clinical trials and FDA approval processes. They highlight the promise of regenerative therapies in restoring health and the need for continued innovation in healthcare.

Title: Pioneering Innovation in Regenerative Medicine and Stem Cell Therapy with Dr. Robin Smith

Guests: Dr. Robin Smith & Dr. Andrew Von Eschenbach

Key Timestamps:

• (00:00) Introduction to Regenerative Medicine
• (03:11) The Evolution of Stem Cell Therapy
• (05:50) Understanding Regenerative Medicine
• (09:10) Applications and Public Interest in Stem Cell Therapy
• (11:51) The Role of Exosomes in Regenerative Medicine
• (14:46) Current Trends and Companies in Regenerative Medicine
• (17:57) Promise vs. Peril in Regenerative Medicine
• (21:04) Challenges in Clinical Trials and FDA Approval
• (24:02) The Future of Regenerative Medicine
• (26:57) Global Perspectives on Stem Cell Therapy
• (30:01) The Role of Innovation in US Healthcare
• (32:47) Conclusion and Future Directions

Key Takeaways:

• Regenerative medicine aims to restore health, not just eliminate disease.
• Stem cells have been used in clinical settings for decades, primarily in oncology.
• Exosomes play a crucial role in cell communication and regenerative therapies.
• The public is increasingly interested in the applications of stem cell therapy.
• Clinical trials are essential for proving the safety and efficacy of new treatments.
• Innovation and funding are critical for advancing regenerative medicine.
• The FDA plays a significant role in regulating stem cell therapies.
• Different sources of stem cells can lead to different therapeutic outcomes.
• The complexity of creating new organs presents challenges in regenerative medicine.
• Global perspectives on stem cell therapy vary, with some countries advancing faster than others. ⁠

⁠linkedin.com/in/robinlsmith-mdmba⁠

⁠linkedin.com/in/andrew-von-eschenbach-m-d-9439ab10⁠

⁠www.scale-community.com⁠

About the Guests:

Dr. Robin L. Smith, doctor, author, and entrepreneur, is transforming healthcare through stem cell therapy, regenerative medicine, and predictive analytics. With expertise in M&A, FDA regulatory advancements, and industry turnarounds, she drives innovation and shapes the future of patient care.

Dr. Andrew Von Eschenbach, M.D., former FDA Commissioner and NCI Director, advanced regulatory science, streamlined drug approvals, and prioritized innovation in medical products. His leadership focused on cancer research, prevention, and improving public health outcomes.

Keywords:

regenerative medicine, stem cell therapy, exosomes, FDA approval, clinical trials, healthcare innovation, oncology, musculoskeletal disease, tissue engineering, health restoration, Analyzing Healthcare, Roy Bejarano, Jason Schifman, Healthcare Leadership, Healthcare Trends

Roy Bejarano sits down with Dr. Robin Smith and Dr. Andrew Von Eschenbach as they delve into the evolving field of regenerative medicine, focusing on stem cell therapy and its applications. In this episode, they discuss the history, current trends, and future potential of regenerative medicine, emphasizing the importance of exosomes and the challenges faced in clinical trials and FDA approval processes. They highlight the promise of regenerative therapies in restoring health and the need for continued innovation in healthcare.

Title: Pioneering Innovation in Regenerative Medicine and Stem Cell Therapy with Dr. Robin Smith

Guests: Dr. Robin Smith & Dr. Andrew Von Eschenbach

Key Timestamps:

• (00:00) Introduction to Regenerative Medicine
• (03:11) The Evolution of Stem Cell Therapy
• (05:50) Understanding Regenerative Medicine
• (09:10) Applications and Public Interest in Stem Cell Therapy
• (11:51) The Role of Exosomes in Regenerative Medicine
• (14:46) Current Trends and Companies in Regenerative Medicine
• (17:57) Promise vs. Peril in Regenerative Medicine
• (21:04) Challenges in Clinical Trials and FDA Approval
• (24:02) The Future of Regenerative Medicine
• (26:57) Global Perspectives on Stem Cell Therapy
• (30:01) The Role of Innovation in US Healthcare
• (32:47) Conclusion and Future Directions

Key Takeaways:

• Regenerative medicine aims to restore health, not just eliminate disease.
• Stem cells have been used in clinical settings for decades, primarily in oncology.
• Exosomes play a crucial role in cell communication and regenerative therapies.
• The public is increasingly interested in the applications of stem cell therapy.
• Clinical trials are essential for proving the safety and efficacy of new treatments.
• Innovation and funding are critical for advancing regenerative medicine.
• The FDA plays a significant role in regulating stem cell therapies.
• Different sources of stem cells can lead to different therapeutic outcomes.
• The complexity of creating new organs presents challenges in regenerative medicine.
• Global perspectives on stem cell therapy vary, with some countries advancing faster than others. ⁠

linkedin.com/in/robinlsmith-mdmba

linkedin.com/in/andrew-von-eschenbach-m-d-9439ab10

www.scale-community.com

About the Guests:

Dr. Robin L. Smith, doctor, author, and entrepreneur, is transforming healthcare through stem cell therapy, regenerative medicine, and predictive analytics. With expertise in M&A, FDA regulatory advancements, and industry turnarounds, she drives innovation and shapes the future of patient care.

Dr. Andrew Von Eschenbach, M.D., former FDA Commissioner and NCI Director, advanced regulatory science, streamlined drug approvals, and prioritized innovation in medical products. His leadership focused on cancer research, prevention, and improving public health outcomes.

Keywords:

regenerative medicine, stem cell therapy, exosomes, FDA approval, clinical trials, healthcare innovation, oncology, musculoskeletal disease, tissue engineering, health restoration, Analyzing Healthcare, Roy Bejarano, Jason Schifman, Healthcare Leadership, Healthcare Trends